Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Mohammad Ashraf Chaudhary, PhD
Pfizer Inc., Collegeville, PA, USA
Poster(s):
(T 95) A post-hoc assessment of the impact of headache-free interictal period duration and every other day treatment with rimegepant on quality of life scores in a 12-week randomized placebo-controlled trial of migraine prevention
